WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

Nov 25, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-11-22

Reporting Person: FEDERICI WILLIAM J (Sr. VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-22	Common Stock	M	36000.0000	$12.7650	Acquired	224446.5626	Direct
2013-11-22	Common Stock	S	36000.0000	$48.3412	Disposed	188446.5626	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-22	Stock Option (Right to Buy)	$12.7650	M	36000.0000	Disposed	2015-03-09	Common Stock (36000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1013.9554	Indirect
Common Stock	10033.9076	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold on the same date in multiple transactions at prices ranging from $48.25 to $48.65, inclusive. The reporting person undertakes to provide to issuer, any security holder of issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.